{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:33:52Z","timestamp":1740123232560,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T00:00:00Z","timestamp":1662940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T00:00:00Z","timestamp":1662940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s11033-022-07796-1","type":"journal-article","created":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T18:03:40Z","timestamp":1663005820000},"page":"10339-10346","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Asian-specific 3\u2019UTR variant in CDKN2B associated with risk of pituitary adenoma"],"prefix":"10.1007","volume":"49","author":[{"given":"Byeong Ju","family":"Youn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Sub","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suhg","family":"Namgoong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyoung Hyo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In Ki","family":"Baek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seon-Jin","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eui Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Hee","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1732-7838","authenticated-orcid":false,"given":"Hyoung Doo","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,12]]},"reference":[{"issue":"4","key":"7796_CR1","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.ncl.2016.06.014","volume":"34","author":"KA McNeill","year":"2016","unstructured":"McNeill KA (2016) Epidemiology of Brain Tumors. Neurol Clin 34(4):981\u2013998","journal-title":"Neurol Clin"},{"issue":"6","key":"7796_CR2","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1227\/01.NEU.0000188281.91351.B9","volume":"57","author":"EB Claus","year":"2005","unstructured":"Claus EB, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M, Black PM (2005) Epidemiology of intracranial meningioma. Neurosurgery 57(6):1088\u20131095 discussion \u2013 95","journal-title":"Neurosurgery"},{"issue":"2","key":"7796_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.critrevonc.2008.01.010","volume":"67","author":"C Marosi","year":"2008","unstructured":"Marosi C, Hassler M, Roessler K, Reni M, Sant M, Mazza E et al (2008) Meningioma Crit reviews oncology\/hematology 67(2):153\u2013171","journal-title":"Meningioma Crit reviews oncology\/hematology"},{"issue":"7","key":"7796_CR4","first-page":"896","volume":"16","author":"QT Ostrom","year":"2014","unstructured":"Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE et al (2014) The epidemiology of glioma in adults: a \u201cstate of the science\u201d review. Neurooncology 16(7):896\u2013913","journal-title":"Neurooncology"},{"key":"7796_CR5","doi-asserted-by":"publisher","first-page":"15017","DOI":"10.1038\/nrdp.2015.17","volume":"1","author":"M Weller","year":"2015","unstructured":"Weller M, Wick W, Aldape K, Brada M, Berger M, Pfister SM et al (2015) Glioma Nat reviews Disease primers 1:15017","journal-title":"Glioma Nat reviews Disease primers"},{"issue":"5","key":"7796_CR6","first-page":"319","volume":"88","author":"MG Lake","year":"2013","unstructured":"Lake MG, Krook LS, Cruz SV (2013) Pituitary adenomas: an overview. Am Family Phys 88(5):319\u2013327","journal-title":"Am Family Phys"},{"doi-asserted-by":"crossref","unstructured":"Lim CT, Korbonits M (2018) Update on the Clinicopathology of Pituitary Adenomas. Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. ;24(5):473 \u2013 88","key":"7796_CR7","DOI":"10.4158\/EP-2018-0034"},{"issue":"2","key":"7796_CR8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s11060-018-03082-y","volume":"142","author":"LH Kim","year":"2019","unstructured":"Kim LH, Kim JH, Namgoong S, Cheong HS, Yoon SJ, Kim EH et al (2019) A PHLDB1 variant associated with the nonfunctional pituitary adenoma. J Neurooncol 142(2):223\u2013229","journal-title":"J Neurooncol"},{"issue":"7 Suppl","key":"7796_CR9","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1002\/cncr.23741","volume":"113","author":"ML Bondy","year":"2008","unstructured":"Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS, Davis FG, Il\u2019yasova D et al (2008) Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 113(7 Suppl):1953\u20131968","journal-title":"Cancer"},{"key":"7796_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3389\/fendo.2018.00405","volume":"9","author":"Y Kong","year":"2018","unstructured":"Kong Y, Hsieh CH, Alonso LC (2018) ANRIL: A lncRNA at the CDKN2A\/B Locus With Roles in Cancer and Metabolic Disease. Front Endocrinol 9:405","journal-title":"Front Endocrinol"},{"issue":"4","key":"7796_CR11","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.bbrc.2012.02.050","volume":"419","author":"A Congrains","year":"2012","unstructured":"Congrains A, Kamide K, Katsuya T, Yasuda O, Oguro R, Yamamoto K et al (2012) CVD-associated non-coding RNA, ANRIL, modulates expression of atherogenic pathways in VSMC. Biochem Biophys Res Commun 419(4):612\u2013616","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"7796_CR12","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/path.833","volume":"193","author":"N Seemann","year":"2001","unstructured":"Seemann N, Kuhn D, Wrocklage C, Keyvani K, Hackl W, Buchfelder M et al (2001) CDKN2A\/p16 inactivation is related to pituitary adenoma type and size. J Pathol 193(4):491\u2013497","journal-title":"J Pathol"},{"issue":"5","key":"7796_CR13","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/jnen\/64.5.398","volume":"64","author":"A Ogino","year":"2005","unstructured":"Ogino A, Yoshino A, Katayama Y, Watanabe T, Ota T, Komine C et al (2005) The p15(INK4b)\/p16(INK4a)\/RB1 pathway is frequently deregulated in human pituitary adenomas. J Neuropathol Exp Neurol 64(5):398\u2013403","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6456","key":"7796_CR14","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/366704a0","volume":"366","author":"M Serrano","year":"1993","unstructured":"Serrano M, Hannon GJ, Beach D (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D\/CDK4. Nature 366(6456):704\u2013707","journal-title":"Nature"},{"issue":"6494","key":"7796_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/371257a0","volume":"371","author":"GJ Hannon","year":"1994","unstructured":"Hannon GJ, Beach D (1994) p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 371(6494):257\u2013261","journal-title":"Nature"},{"issue":"1","key":"7796_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1530\/eje.0.1360074","volume":"136","author":"K Yoshimoto","year":"1997","unstructured":"Yoshimoto K, Tanaka C, Yamada S, Kimura T, Iwahana H, Sano T et al (1997) Infrequent mutations of p16INK4A and p15INK4B genes in human pituitary adenomas. Eur J Endocrinol 136(1):74\u201380","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"7796_CR17","first-page":"922","volume":"78","author":"J Zhu","year":"1994","unstructured":"Zhu J, Leon SP, Beggs AH, Busque L, Gilliland DG, Black PM (1994) Human pituitary adenomas show no loss of heterozygosity at the retinoblastoma gene locus. J Clin Endocrinol Metab 78(4):922\u2013927","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"7796_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/(SICI)1097-0215(19960703)67:1<16::AID-IJC4>3.0.CO;2-2","volume":"67","author":"M Woloschak","year":"1996","unstructured":"Woloschak M, Yu A, Xiao J, Post KD (1996) Abundance and state of phosphorylation of the retinoblastoma gene product in human pituitary tumors. Int J Cancer 67(1):16\u201319","journal-title":"Int J Cancer"},{"issue":"8","key":"7796_CR19","first-page":"1613","volume":"55","author":"L Pei","year":"1995","unstructured":"Pei L, Melmed S, Scheithauer B, Kovacs K, Benedict WF, Prager D (1995) Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB. Cancer Res 55(8):1613\u20131616","journal-title":"Cancer Res"},{"issue":"2","key":"7796_CR20","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/1097-0142(19940715)74:2<693::AID-CNCR2820740223>3.0.CO;2-P","volume":"74","author":"M Woloschak","year":"1994","unstructured":"Woloschak M, Roberts JL, Post KD (1994) Loss of heterozygosity at the retinoblastoma locus in human pituitary tumors. Cancer 74(2):693\u2013696","journal-title":"Cancer"},{"issue":"3","key":"7796_CR21","first-page":"644","volume":"77","author":"VL Cryns","year":"1993","unstructured":"Cryns VL, Alexander JM, Klibanski A, Arnold A (1993) The retinoblastoma gene in human pituitary tumors. J Clin Endocrinol Metab 77(3):644\u2013646","journal-title":"J Clin Endocrinol Metab"},{"issue":"13","key":"7796_CR22","first-page":"2703","volume":"57","author":"WE Farrell","year":"1997","unstructured":"Farrell WE, Simpson DJ, Bicknell JE, Talbot AJ, Bates AS, Clayton RN (1997) Chromosome 9p deletions in invasive and noninvasive nonfunctional pituitary adenomas: the deleted region involves markers outside of the MTS1 and MTS2 genes. Cancer Res 57(13):2703\u20132709","journal-title":"Cancer Res"},{"issue":"9","key":"7796_CR23","first-page":"1473","volume":"3","author":"YX Hu","year":"1997","unstructured":"Hu YX, Watanabe H, Ohtsubo K, Yamaguchi Y, Ha A, Okai T et al (1997) Frequent loss of p16 expression and its correlation with clinicopathological parameters in pancreatic carcinoma. Clin Cancer Res 3(9):1473\u20131477","journal-title":"Clin Cancer Res"},{"issue":"10","key":"7796_CR24","first-page":"17480","volume":"8","author":"H Lu","year":"2015","unstructured":"Lu H, Yang Y, Wang J, Liu Y, Huang M, Sun X et al (2015) The CDKN2A-CDKN2B rs4977756 polymorphism and glioma risk: a meta-analysis. Int J Clin Exp Med 8(10):17480\u201317488","journal-title":"Int J Clin Exp Med"},{"issue":"8","key":"7796_CR25","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/ng.407","volume":"41","author":"S Shete","year":"2009","unstructured":"Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malmer B et al (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41(8):899\u2013904","journal-title":"Nat Genet"},{"issue":"2","key":"7796_CR26","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s11033-019-05178-8","volume":"47","author":"M Viana-Pereira","year":"2020","unstructured":"Viana-Pereira M, Moreno DA, Linhares P, Amorim J, Nabico R, Costa S et al (2020) Replication of GWAS identifies RTEL1, CDKN2A\/B, and PHLDB1 SNPs as risk factors in Portuguese gliomas patients. Mol Biol Rep 47(2):877\u2013886","journal-title":"Mol Biol Rep"},{"issue":"1","key":"7796_CR27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.9758\/cpn.2017.15.1.53","volume":"15","author":"J Zhao","year":"2017","unstructured":"Zhao J, Wu X, Nie S, Gao X, Sun J, Li K et al (2017) Association of CDKN2B-AS1 rs1333049 with Brain Diseases: A Case-control Study and a Meta-analysis. Clin Psychopharmacol neuroscience: official Sci J Korean Coll Neuropsychopharmacol 15(1):53\u201358","journal-title":"Clin Psychopharmacol neuroscience: official Sci J Korean Coll Neuropsychopharmacol"},{"issue":"8","key":"7796_CR28","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1093\/carcin\/bgv074","volume":"36","author":"M Adel Fahmideh","year":"2015","unstructured":"Adel Fahmideh M, Lavebratt C, Schuz J, Roosli M, Tynes T, Grotzer MA et al (2015) CCDC26, CDKN2BAS, RTEL1 and TERT Polymorphisms in pediatric brain tumor susceptibility. Carcinogenesis 36(8):876\u2013882","journal-title":"Carcinogenesis"},{"issue":"10","key":"7796_CR29","doi-asserted-by":"publisher","first-page":"e0163067","DOI":"10.1371\/journal.pone.0163067","volume":"11","author":"AM Dahlin","year":"2016","unstructured":"Dahlin AM, Wibom C, Ghasimi S, Brannstrom T, Andersson U, Melin B (2016) Relation between Established Glioma Risk Variants and DNA Methylation in the Tumor. PLoS ONE 11(10):e0163067","journal-title":"PLoS ONE"},{"issue":"3","key":"7796_CR30","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s11060-016-2066-4","volume":"127","author":"S Ghasimi","year":"2016","unstructured":"Ghasimi S, Wibom C, Dahlin AM, Brannstrom T, Golovleva I, Andersson U et al (2016) Genetic risk variants in the CDKN2A\/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma. J Neurooncol 127(3):483\u2013492","journal-title":"J Neurooncol"},{"issue":"3","key":"7796_CR31","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1001\/archneurol.2010.4","volume":"67","author":"Y Liu","year":"2010","unstructured":"Liu Y, Shete S, Hosking FJ, Robertson LB, Bondy ML, Houlston RS (2010) New insights into susceptibility to glioma. Arch Neurol 67(3):275\u2013278","journal-title":"Arch Neurol"},{"issue":"8","key":"7796_CR32","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/ng.408","volume":"41","author":"M Wrensch","year":"2009","unstructured":"Wrensch M, Jenkins RB, Chang JS, Yeh RF, Xiao Y, Decker PA et al (2009) Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 41(8):905\u2013908","journal-title":"Nat Genet"},{"issue":"1","key":"7796_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/nop\/npv026","volume":"3","author":"T Rice","year":"2016","unstructured":"Rice T, Lachance DH, Molinaro AM, Eckel-Passow JE, Walsh KM, Barnholtz-Sloan J et al (2016) Understanding inherited genetic risk of adult glioma - a review. Neuro-oncology Pract 3(1):10\u201316","journal-title":"Neuro-oncology Pract"},{"issue":"3","key":"7796_CR34","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.phrp.2012.07.004","volume":"3","author":"SY Cho","year":"2012","unstructured":"Cho SY, Hong EJ, Nam JM, Han B, Chu C, Park O (2012) Opening of the national biobank of Korea as the infrastructure of future biomedical science in Korea. Osong public health and research perspectives 3(3):177\u2013184","journal-title":"Osong public health and research perspectives"},{"issue":"7571","key":"7796_CR35","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"C Genomes Project","year":"2015","unstructured":"Genomes Project C, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM et al (2015) A global reference for human genetic variation. Nature 526(7571):68\u201374","journal-title":"Nature"},{"issue":"2","key":"7796_CR36","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","volume":"21","author":"JC Barrett","year":"2005","unstructured":"Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21(2):263\u2013265","journal-title":"Bioinformatics"},{"issue":"4","key":"7796_CR37","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1086\/319501","volume":"68","author":"M Stephens","year":"2001","unstructured":"Stephens M, Smith NJ, Donnelly P (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68(4):978\u2013989","journal-title":"Am J Hum Genet"},{"doi-asserted-by":"crossref","unstructured":"Kinnersley B, Houlston RS, Bondy ML (2018) Genome-Wide Association Studies in Glioma. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 27:418\u20134284","key":"7796_CR38","DOI":"10.1158\/1055-9965.EPI-17-1080"},{"key":"7796_CR39","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1146\/annurev.genom.4.070802.110226","volume":"4","author":"SA Tishkoff","year":"2003","unstructured":"Tishkoff SA, Verrelli BC (2003) Patterns of human genetic diversity: implications for human evolutionary history and disease. Annu Rev Genom Hum Genet 4:293\u2013340","journal-title":"Annu Rev Genom Hum Genet"},{"issue":"2","key":"7796_CR40","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/em.22159","volume":"59","author":"B Knox","year":"2018","unstructured":"Knox B, Wang Y, Rogers LJ, Xuan J, Yu D, Guan H et al (2018) A functional SNP in the 3\u2019-UTR of TAP2 gene interacts with microRNA hsa-miR-1270 to suppress the gene expression. Environ Mol Mutagen 59(2):134\u2013143","journal-title":"Environ Mol Mutagen"},{"issue":"3","key":"7796_CR41","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1158\/0008-5472.CAN-14-2101","volume":"75","author":"BM Ryan","year":"2015","unstructured":"Ryan BM, Robles AI, McClary AC, Haznadar M, Bowman ED, Pine SR et al (2015) Identification of a functional SNP in the 3\u2019UTR of CXCR2 that is associated with reduced risk of lung cancer. Cancer Res 75(3):566\u2013575","journal-title":"Cancer Res"},{"key":"7796_CR42","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3389\/fendo.2019.00290","volume":"10","author":"BM Hauser","year":"2019","unstructured":"Hauser BM, Lau A, Gupta S, Bi WL, Dunn IF (2019) The Epigenomics of Pituitary Adenoma. Front Endocrinol 10:290","journal-title":"Front Endocrinol"},{"issue":"6","key":"7796_CR43","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S0213-9111(08)75363-9","volume":"22","author":"A Ruano-Ravina","year":"2008","unstructured":"Ruano-Ravina A, Perez-Rios M, Barros-Dios JM (2008) Population-based versus hospital-based controls: are they comparable? Gac Sanit 22(6):609\u2013613","journal-title":"Gac Sanit"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07796-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-022-07796-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07796-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T12:39:50Z","timestamp":1667133590000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-022-07796-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,12]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["7796"],"URL":"https:\/\/doi.org\/10.1007\/s11033-022-07796-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2022,9,12]]},"assertion":[{"value":"25 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}